| Samuel O. Antwi, Ph.D. |
|
Investigates genetic, molecular and nongenetic risk factors associated with liver and pancreatic cancers. |
| Panagiotis (Panos) Z. Anastasiadis, Ph.D. |
Cell Adhesion and Metastasis Lab |
Explores cancer biology with a goal to develop new therapies that can control the progression and spread of tumors. |
| Veronique Belzil, Ph.D., M.S. |
Translational and Integrative Omics for Neurodegeneration Lab |
Examines genomic, epigenomic and transcriptomic mediators of neurodegeneration to evaluate their potential as biomarkers and therapeutic targets. |
| Santanu Bhattacharya, Ph.D. |
|
Implements nanomaterials to impact cancer biology for assessment of disease processes and improved detection in pancreatic cancer. |
| Thomas Caulfield, Ph.D. |
Drug Discovery, Design and Optimization for Novel Therapeutics Lab |
Studies targets with clinical potential for future "drugability," especially at the atomic level of detail that governs the interactions of the cellular components. |
| Eduardo N. Chini, M.D., Ph.D. |
|
Focuses on enzymatic pathways for drug targeting to treat obesity and metabolic diseases. Also, exploring the role of metabolism and nutrition in kidney disease. |
| John A. Copland III, Ph.D., and Nathaniel E. Wiest, M.D., Ph.D. |
Cancer Biology and Translational Oncogenomics Lab |
Researches renal, thyroid and breast cancer with a focus on molecular signaling pathways and molecular-targeted therapeutics. |
| DeLisa Fairweather, Ph.D. |
Translational Cardiovascular Disease Research Lab |
Investigates the pathogenesis of disease to discover novel therapies for patients with myocarditis and other cardiovascular and autoimmune diseases. |
| Baoan Ji, M.D., Ph.D. |
|
Explores novel therapeutic and preventative strategies for pancreatic inflammation and cancer. |
| Verline Justilien, Ph.D. |
Molecular Mechanisms of Tumorigenesis Lab |
Examines the role members of the protein kinase C (PKC) family of protein kinases play in the initiation, promotion and metastasis of colon and lung cancer. |
| Takahisa Kanekiyo, M.D., Ph.D.,and James F. Meschia, M.D. |
|
Investigates the pathogenesis of vascular cognitive impairment and Alzheimer's disease with a specific focus on contributions of cellular senescence and genetic factors. |
| Adi Narayana Kunamneni, Ph.D. |
Therapeutic Antibody Discovery Lab |
Develops novel antibody therapeutics and diagnostics for infectious diseases, cancer, chronic pain and ischemic stroke. |
| Keith L. Knutson, Ph.D. |
|
Looks at basic, translational, and clinical applications of immunotherapy for the treatment and prevention of breast and ovarian cancers. |
| Debabrata (Dev) Mukhopadhyay, Ph.D.,Ramcharan Singh Angom, Ph.D., and Tanmay A. Kulkarni, Ph.D. |
Tumor Angiogenesis and Vascular Biology Lab |
Studies how new blood vessels develop in tumor formation and cardiovascular diseases. Formats targeted drug delivery and translational nanomedicine for cancer and other diseases. |
| Krishnendu Pal, Ph.D. |
|
Focuses on targeted drug delivery. Studies cancer biology to understand the signaling pathways that trigger resistance to chemotherapy and discover the means to override them. |
| Tushar C. Patel, M.B., Ch.B. |
Molecular Hepatology Lab |
Investigates the cellular and molecular mechanisms that contribute to the development of liver and biliary tract cancers. |
| Tushar C. Patel, M.B., Ch.B., and Christine Mehner, M.D., Ph.D. |
Space medicine: Studying human cells in space (video) and Real versus simulated galactic cosmic radiation for investigating cancer risk in the hematopoietic system — are we comparing apples to apples? |
Builds and tests miniaturized automated devices to assess human cells in outer space. Encompasses, cell culture, protein assessment, 3D modeling, prototyping and engineering out of plastics and metal, coding (C++, Python) of embedded systems for motor and camera control. |
| Asher A. Chanan-Khan, M.B.B.S., M.D. |
|
Researches biomolecular and immunologic mechanisms associated with drug resistance in B-cell cancers. |
| Hong Qin, M.D., Ph.D., and Alak Manna, Ph.D. |
|
Develops antibody-based therapeutics to treat cancers such as lymphoma and leukemia. Specializes in translating research finding to workable clinical applications. |
| Alfredo Quinones-Hinojosa, M.D. |
Brain Tumor Stem Cell Research Lab |
Studies cancer cell invasiveness and migration to better understand tumor progression and identify new treatments for brain tumors. |
| Owen A. Ross, Ph.D. |
Parkinson's Disease Lab and Stroke and Vascular Disease Lab |
Examines the genetics of aging, age-related disorders and related movement disorders.
|
| Peter Storz, Ph.D., and Alicia K. Fleming Martinez, Ph.D. |
Tumor Development, Immunology and Progression Lab |
Investigates the cellular signaling and cross-talk mechanisms that contribute to the tumorigenesis and aggressiveness of pancreatic cancer and invasive breast cancer |
| Marka M. Van Blitterswijk, M.D., Ph.D. |
Genomics of ALS and Integrative Analytics Lab |
Engages in patient-oriented research to discover new genes, biomarkers, disease modifiers and therapeutic targets for neurodegenerative diseases using state-of-the-art technologies and analyses, including long-read sequencing, single-cell RNA sequencing, cerebral organoid culture, bioinformatics and machine learning. |
| Yongjie Zhang, Ph.D. |
Pathomechanisms of Neurodegeneration in the Frontotemporal Dementia and Amyotrophic Lateral Sclerosis Lab |
Identifies and designs target-specific therapies to treat frontotemporal dementia and amyotrophic lateral sclerosis. |